Press Releases

Belén Garijo, MD
Belén Garijo, MD
zoom in
Merck KGaA Strengthens Executive Board
Darmstadt, Germany, September 18, 2014 – Merck KGaA today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belén Garijo (54) was appointed to the Executive Board to take over leadership for the Pharma business. The management changes will become effective as of January 1, 2015.
 
Investor & Analyst Day on Biopharmaceuticals 2014
Investor & Analyst Day on Biopharmaceuticals 2014
Investor & Analyst Day on Biopharmaceuticals 2014
Darmstadt, Germany, September 18, 2014 – Merck KGaA’s biopharmaceutical business is well on track. This is reflected for example by the successful execution of growth initiatives and by progress in the pipeline. This progress can be seen particularly in Immuno-Oncology, among others. Additionally Merck KGaA, Darmstadt, Germany, plans to step up investments in its Biosimilars unit next year.
 
New Merck KGaA Headquarters
The new modular Innovation Center at the Darmstadt site
zoom in
New Merck KGaA Headquarters Starts Taking Shape
Darmstadt, Germany, September 1, 2014 – The expansion of the Merck KGaA site in Darmstadt into a contemporary global headquarters announced at the end of 2013 is clearly taking shape. A groundbreaking ceremony today marked the start of construction on a modular Innovation Center at the Darmstadt site.
 
 
 
 
 
 
 
 
 
 

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

MERCK FINANCIAL REPORT

2nd quarter 2014Merck Interim Report
Merck on Facebook
Merck on Twitter
 
  
Read more on M - The Explorer Magazine

Pioneering work for allergy patients

Whether allergies are due to heredity, environmental pollution or excessive hygiene, they are troublesome illnesses of the immune system whose effects should not be underestimated.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Partnerships for better early diagnosis

Few people know the symptoms of a head and neck tumor. Merck is therefore supporting head and neck tumor awareness week again this year.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Honeybees sweeten “Go Green” initiative

In the town of Aubonne on the north side of Lake Geneva in Switzerland, EMD Serono employees produce not only cutting-edge biotechnological medicines, but their own honey too.

Read more on M - The Explorer Magazine